Cypress Capital Group acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,443 shares of the medical equipment provider’s stock, valued at approximately $784,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in shares of Intuitive Surgical during the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. TD Capital Management LLC grew its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. 83.64% of the stock is owned by institutional investors.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Stock Performance
Intuitive Surgical stock opened at $429.59 on Monday. The stock’s 50 day simple moving average is $458.68 and its two-hundred day simple moving average is $497.84. The stock has a market cap of $154.00 billion, a price-to-earnings ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business’s revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.78 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Where to Find Earnings Call Transcripts
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.